The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
In a major reform aimed at improving the ease of doing business in India, the…
José Antonio Kast has officially taken office as the new President of Chile, marking a…
Child marriage is a serious social issue in India, affecting the rights, health, and education…
Prime Minister Narendra Modi recently dedicated a modern elevated road corridor connecting Pandu Port to…
The Union Ministry of Jal Shakti is taking big steps under Jal Jeevan Mission (JJM)…
The Ministry of Housing & Urban Affairs (MoHUA) hosted the AMRUT Mitra Mahotsav 2026 at…